Compositions and methods for the early diagnosis of ovarian cancer

Details for Australian Patent Application No. 2001239832 (hide)

Owner The Board of Trustees of the University of Arkansas

Inventors O'Brien, Timothy J.

Agent Callinan

Pub. Number AU-B-2001239832

PCT Pub. Number WO01/62271

Priority 09/510,738 22.02.00 US

Filing date 20 February 2001

Wipo publication date 3 September 2001

Acceptance publication date 30 September 2004

International Classifications

A61K 038/17 Medicinal preparations containing peptides - from animals

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 014/435 Peptides having more than 20 amino acids - from animals

Event Publications

30 September 2004 Application Accepted

  Published as AU-B-2001239832

27 January 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001239833

2001239831